InBios International, Inc. of Seattle, WA at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair
Manufacturers

InBios International, Inc.

562 1st Avenue South, Suite 600, 98104 Seattle, WA
United States of America

Telephone +1 206 3445821
Fax +1 206 3445823
inquiries@inbios.com

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2017 hall map (Hall 3): stand D29-13

Fairground map

MEDICA 2017 fairground map: Hall 3

Our range of products

Product categories

Our products

Product category: General Diagnostics

CHIKjj Detect™IgG ELISA Kit

CE Marked

The CHIKjj DetectTM IgG ELISA is designed for the qualitative detection of IgM antibodies present in human serum targeting chikungunya virus E2/E1 proteins. This test is for the presumptive clinical laboratory diagnosis of chikungunya virus infection. This assay is intended for use only in patients with clinical symptoms consistent with chikungunya infection.

The complete kit includes one 96 well strippable plate with all necessary reagents and controls.

More Less

Product category: General Diagnostics

Lepto Detect™ IgM ELISA System

In Development – Ask About Availability

The Lepto Detect™ IgM ELISA System for exposure to leptospira species is an ELISA system for the detection of IgM antibodies in human serum to Leptospira-derived antigen. For research use only. Not for use in diagnostic procedures.

The complete kit includes one 96 well strippable plate with all necessary reagents and controls.

More Less

Product category: General Diagnostics

ZIKV Detect™IgM Capture ELISA Kit

For Use Only Under the FDA’s Emergency Use Authorization – Rx ONLY

The ZIKV DetectTM IgM Capture ELISA is intended for the presumptive detection of Zika virus IgM antibodies in human sera collected from individuals meeting CDC Zika virus clinical criteria (e.g., a history of clinical signs and symptoms associated with Zika virus infection) and/or CDC Zika virus epidemiological criteria (e.g., history of residence in or travel to a geographic region with active Zika transmission at the time of travel, or other epidemiological criteria for which Zika virus testing may be indicated). The assay is intended for use in laboratories in the United States that are certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories, consistent with the latest CDC guideline for the diagnosis of Zika virus infection.

Assay results are for the presumptive detection of IgM antibodies to Zika virus (ZIKV). Reactive results are not definitive for the diagnosis of Zika virus infection. False positive results are possible in patients with a history of infection with other Flaviviruses. Confirmation of the presence of anti-Zika IgM antibodies in presumptive positive specimens requires additional testing according to the latest CDC guideline for the diagnosis of Zika virus infection. Within the United States and its territories, laboratories are required to report presumptive positive results to the appropriate public health authorities.

Results of this test cannot be used as the sole basis of patient management decisions and must be combined with clinical observations, patient history, epidemiological information, and other laboratory evidences. Zika IgM levels over the course of illness are not well characterized. IgM levels are variable, may be detectable near day four post onset of symptoms and persist up to approximately 12 weeks following initial infection.

Negative results do not preclude the possibility of Zika virus infection, past or present. Negative results may be seen in specimens collected before day four post onset of symptoms or after the window of detectable IgM closes.

The ZIKV Detect™ IgM Capture ELISA is intended for use by trained laboratory personnel who are proficient in performing and interpreting immunoassays.The ZIKV Detect™ IgM Capture ELISA is only for use under the FDA’s Emergency Use Authorization.

PROTOCOL USE LIMITATIONS
The ZIKV Detect™ IgM Capture ELISA described here has not been extensively tested with clinical specimens. Modifications of these assays (i.e., use of platforms or chemistries other than those described) are not permitted

  • This test has not been FDA cleared or approved;
  • This test has been authorized by FDA under an EUA for use by authorized laboratories;
  • This test has been authorized only for the diagnosis of Zika virus infection and not for any other viruses or pathogens; and
  • This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

More Less

Product category: General Diagnostics

Kalazar Detect™ System for Visceral Leishmaniasis

Research Use Only

The Kalazar DetectTM ELISA System for diagnosis of Visceral Leishmaniasis is an ELISA assay system for the detection of antibodies to L. donovani complex derived proprietary recombinant antigens in serum. This test is for research use only. Not for use in diagnostic procedures.

The complete kit includes one 96 well strippable plate with all necessary reagents and controls.

More Less

Product category: General Diagnostics

Monoclonal Antibodies for Infectious Agents

Affinity Purified, Highly-Specific, Characterized Reagents

InBios is a leader in infectious disease reagent and antibody development. We offer direct sales of our most sought-after monoclonal antibody reagents. Wet, frozen reagents can be purchased in 100µl, 200µl or custom quantities. These reagents are ready for your use in a variety of applications: ELISA, Western blot, and rapid immunochromatographic tests.*

All of our mouse-derived hybridomas are column affinity purified for your immediate use. Conjugates of many of our antibodies are also available for purchase. Refer to the list of monoclonal antibodies below for specific reagents that can be used for the detection of: Plasmodium, Burkholderia, Mycobacterium, Leishmania, E. coli 0157, Shigella, Campylobacter, Cryptosporidium, Norovirus, Rotavirus, Flaviviruses, Sandfly virus, Dengue virus, West Nile virus, and Saint Louis encephalitis virus.

* For Research Use Only (RUO)

More Less

About us

Company details

Accurate, Innovative, High-Quality Diagnostics

InBios is a leading biotechnology company based in Seattle, Washington (USA). We specialize in the design, development, and manufacture of immunodiagnostic devices for infectious diseases. As such, we have specifically targeted those diseases that afflict tens of millions of people worldwide. We serve the global public marketplace by providing superior quality products that are accurate, easy to use and cost effective.

We have a competent and dedicated staff. Our team of scientists and engineers have over 30 years of expertise in developing and manufacturing in vitro diagnostic tests. InBios’ staff of scientists and engineers develop and manufacture high-quality, cost-effective, and accurate immunodiagnostic products. We have recruited a diverse, well-trained and highly educated group of dedicated professionals, which enables us to bring you reliable and practical solutions for challenging infectious disease diagnoses.

InBios has a long history of market leadership with a number of its products. We have a world-class technology development program. A number of our quality reagents have been licensed for research and emerging disease threat diagnostic applications. We have partnered with other private companies, federal laboratories and academia to bring our customers the best scientific solutions for their diagnostic needs.

We offer an impressive line of FDA cleared and USDA licensed products. All of our products are manufactured in the United States under rigorous quality control and performance validation procedures. Our facility is ISO 13485:2003 certified. All diagnostic products are manufactured under GMP, and most are CE Marked according to EC IVD Directive 98/79/EC.

InBios products are available in a variety of convenient formats. We continue to develop new products to complement our existing product range through Research and Development. We can assist you by providing an Analyte Specific Reagent or a custom-built assay through our Contract Manufacturing business unit. We also have the capability to rapidly scale-up production in response to public health emergencies.

More Less